Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio

scientific article published in September 2017

Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/NEUONC/NOX162
P932PMC publication ID5909665
P698PubMed publication ID29016943

P50authorMichael PlattenQ38799497
Philipp KickingerederQ40394749
Martin BendszusQ40395521
Timothy F. CloughesyQ47159504
Olivier ChinotQ56384070
Thomas SandmannQ57159817
Lauren E AbreyQ114444382
P2093author name stringRoger Henriksson
Benjamin M Ellingson
Wolfgang Wick
Warren P Mason
Alexander Radbruch
Ryo Nishikawa
Martha Nowosielski
Frank Saran
Josep Garcia
Cedric Revil
P2860cites workModes of resistance to anti-angiogenic therapyQ24608005
Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesQ24647449
MGMT gene silencing and benefit from temozolomide in glioblastomaQ27824832
Molecular mechanisms and clinical applications of angiogenesisQ29547314
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisQ29619677
A randomized trial of bevacizumab for newly diagnosed glioblastomaQ30410163
Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristicsQ30870628
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysisQ33370030
Transdifferentiation of glioblastoma cells into vascular endothelial cellsQ34694093
Effects of anti-angiogenesis on glioblastoma growth and migration: model to clinical predictions.Q34703888
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio TrialQ37240846
Clonal evolution of glioblastoma under therapy.Q39704836
Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomasQ40886583
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastomaQ41654243
Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapyQ41809732
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and miceQ42041511
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastomaQ46796397
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR TrialQ48342416
Spatial expression of VEGF-A in human gliomaQ48488963
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.Q55460997
Bevacizumab does not increase the risk of remote relapse in malignant glioma.Q55463287
P433issue4
P921main subjectglioblastomaQ282142
P304page(s)557-566
P577publication date2017-09-01
P1433published inNeuro-OncologyQ15724471
P1476titleRadiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio
P478volume20

Reverse relations

cites work (P2860)
Q58768236Angiogenesis and radiological tumor growth in patients with glioblastoma
Q55456668Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.
Q58568066Evaluating cellularity and structural connectivity on whole brain slides using a custom-made digital pathology pipeline
Q58556522Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1
Q57177114Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
Q54973707Imaging in neuro-oncology.
Q56333957The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Q90583610Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis